![]() |
Name |
4-Methoxybutan-1-ol
|
Molecular Formula | C5H12O2 | |
IUPAC Name* |
4-methoxybutan-1-ol
|
|
SMILES |
COCCCCO
|
|
InChI |
InChI=1S/C5H12O2/c1-7-5-3-2-4-6/h6H,2-5H2,1H3
|
|
InChIKey |
KOVAQMSVARJMPH-UHFFFAOYSA-N
|
|
Synonyms |
4-Methoxybutan-1-ol; 111-32-0; 4-METHOXY-1-BUTANOL; 1-Butanol, 4-methoxy-; Dowanol BMAT; Dowanol bm; Butylene glycol methyl ether; 4-Methoxybutyl alcohol; 1,4-Butanediol Monomethyl Ether; 4-Methoxybutanol; Butylene glycol monomethyl ether; NSC 245191; AH4W8HA8JH; Tetramethylene Glycol Monomethyl Ether; NSC-245191; Dowanal BMAT; 4-Methoxybutanol-1; EINECS 203-858-6; BRN 1732309; 4-methoxy-butan-1-ol; UNII-AH4W8HA8JH; SCHEMBL23986; WLN: Q4O1; DTXSID50149438; BCP23225; ZINC1765882; BBL100500; MFCD00040437; NSC245191; STL554294; AKOS005254381; WT82446; MS-20025; DB-002112; AM20080057; B2402; CS-0150179; FT-0656133; EN300-42852; D78159; Q-103486; Z431605254
|
|
CAS | 111-32-0 | |
PubChem CID | 8107 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 104.15 | ALogp: | 0.1 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 29.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 7 | QED Weighted: | 0.534 |
Caco-2 Permeability: | -4.193 | MDCK Permeability: | 0.00004230 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.047 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.017 |
30% Bioavailability (F30%): | 0.016 |
Blood-Brain-Barrier Penetration (BBB): | 0.393 | Plasma Protein Binding (PPB): | 8.41% |
Volume Distribution (VD): | 0.891 | Fu: | 88.41% |
CYP1A2-inhibitor: | 0.032 | CYP1A2-substrate: | 0.859 |
CYP2C19-inhibitor: | 0.019 | CYP2C19-substrate: | 0.649 |
CYP2C9-inhibitor: | 0.004 | CYP2C9-substrate: | 0.095 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.13 |
CYP3A4-inhibitor: | 0.005 | CYP3A4-substrate: | 0.185 |
Clearance (CL): | 7.324 | Half-life (T1/2): | 0.768 |
hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.042 |
Drug-inuced Liver Injury (DILI): | 0.027 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.029 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.626 | Carcinogencity: | 0.359 |
Eye Corrosion: | 0.902 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.024 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000139 | ![]() |
0.522 | D01QLH | ![]() |
0.323 | ||
ENC000255 | ![]() |
0.407 | D0EP8X | ![]() |
0.276 | ||
ENC000017 | ![]() |
0.391 | D03CHT | ![]() |
0.231 | ||
ENC000049 | ![]() |
0.375 | D07SUG | ![]() |
0.222 | ||
ENC000355 | ![]() |
0.346 | D03HFG | ![]() |
0.212 | ||
ENC000317 | ![]() |
0.343 | D0C1QZ | ![]() |
0.200 | ||
ENC000897 | ![]() |
0.333 | D0MM8N | ![]() |
0.197 | ||
ENC000776 | ![]() |
0.323 | D0AY9Q | ![]() |
0.196 | ||
ENC000274 | ![]() |
0.293 | D0FD0H | ![]() |
0.194 | ||
ENC003693 | ![]() |
0.286 | D00AMQ | ![]() |
0.190 |